Precipio Inc. (PRPO)
9.64
1.33 (15.95%)
At close: Feb 20, 2025, 3:55 PM
10.00
3.73%
After-hours: Feb 20, 2025, 06:57 PM EST
undefined% (undefined)
| Bid | 9.11 |
| Market Cap | 14.29M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.81 |
| PE Ratio (ttm) | -5.33 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 11.5 |
| Volume | 45,781 |
| Avg. Volume (20D) | 6,896 |
| Open | 8.33 |
| Previous Close | 8.31 |
| Day's Range | 8.32 - 9.64 |
| 52-Week Range | 4.31 - 9.64 |
| Beta | undefined |
About PRPO
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the se...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 30, 2017
Employees 51
Stock Exchange NASDAQ
Ticker Symbol PRPO
Website https://www.precipiodx.com
7 months ago
+23.87%
Precipio shares are trading higher after the compa...
Unlock content with
Pro Subscription
